Trials / Unknown
UnknownNCT01108614
Injecting Drug Use Community Intervention Trial
A Randomized Community Intervention Trial on Reducing HIV Infection Among Drug Users Attending Methadone Maintenance Treatment(MMT) and Preventing Secondary Transmission From HIV Positive Clients to Their Sexual Partners in China
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 12,000 (estimated)
- Sponsor
- National Center for AIDS/STD Control and Prevention, China CDC · Other Government
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to reduce the HIV/HCV incidence among the clients attending community-based methadone maintenance treatment (MMT) , and to prevent the secondary sexual transmission from HIV+ clients to their spouse and sex partners, through intensified comprehensive intervention.
Detailed description
Even though National sentinel surveillance data show that the increase rate of HIV new infections among IDUs in China has become stabilized and slowed down, the new HIV infection is still on the rise, especially in the Yunnan, Guizhou, Guangxi, Xinjiang and Sichuan. This study attempts to further reduce the new infection among MMT clients, and particularly to prevent the transmission from HIV infected clients to their sexual partners with comprehensive intervention. The purposes of this study are: 1. To evaluate the effectiveness of comprehensive interventions to decrease the HIV/STIs incidence among MMT clients. 2. To prevent the sexual transmission between those HIV+ clients and their spouse/partners with intensified intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Intervention | Intensive HIV psychological counseling ,Increased methadone dosage under individualized treatment principle, enhance randomized urine test, strengthen family and social support , partner notification and routine HIV testing, condom promotion, STD referral services. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-12-01
- Completion
- 2011-03-01
- First posted
- 2010-04-22
- Last updated
- 2010-05-07
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01108614. Inclusion in this directory is not an endorsement.